首页 产品目录 分子砌块 按官能团 NH-唑类 卡那霉素B氨基甲酸酯

卡那霉素B氨基甲酸酯

(2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-((1R,2S)-2-(6-amino-2-((S)-3-amino-1-(((S)-2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-(((2R,3S,4S)-5-(((2S,3R)-1-((2-((R)-4-((4-((diaminomethylene)amino)butyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl)amino)-1-(1H-imidazol-5-yl)-3-oxopropoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

11031-11-1

中文名称

卡那霉素B氨基甲酸酯

英文名称

(2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-((1R,2S)-2-(6-amino-2-((S)-3-amino-1-(((S)-2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-(((2R,3S,4S)-5-(((2S,3R)-1-((2-((R)-4-((4-((diaminomethylene)amino)butyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl)amino)-1-(1H-imidazol-5-yl)-3-oxopropoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate

别名

ZEOCIN;phleomycin D1;(7R)-N1-[4-[[Amino(imino)methyl]amino]butyl]-7,8-dihydrobleomycinamide;Bleomycinamide, N1-[4-[(aminoiminomethyl)amino]butyl]-7,8-dihydro-;Zeocin (Phleomycin D1, zeomycin);ZEOCINE

标准英文名

(2R,3S,4S,5R,6R)-2-(((2R,3S,4S,5S,6S)-2-((1R,2S)-2-(6-amino-2-((S)-3-amino-1-(((S)-2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidine-4-carboxamido)-3-(((2R,3S,4S)-5-(((2S,3R)-1-((2-((R)-4-((4-((diaminomethylene)amino)butyl)carbamoyl)-4',5'-dihydro-[2,4'-bithiazol]-2'-yl)ethyl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl)amino)-1-(1H-imidazol-5-yl)-3-oxopropoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate

MDL No.

MFCD28100499

分子式

C55H86N20O21S2

分子量

1427.55

精确分子量

1426.57

SMILES

CC1=C(C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCC2=N[C@@H](C3=NC(C(=O)NCCCCN=C(N)N)=CS3)CS2)[C@@H](C)O)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]2O)C2=CN=CN2)N=C([C@H](CC(N)=O)NC[C@H](N)C(N)=O)N=C1N

标准SMILES

CC1C(N)=NC(=NC=1C(=O)N[C@@H]([C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)C1=CN=CN1)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC1=N[C@H](CS1)C1=NC(=CS1)C(=O)NCCCCN=C(N)N)[C@H](CC(N)=O)NC[C@H](N)C(N)=O

用途

Antitumor agent; used clinically for the treatment of squamous cell carcinoma with reduced pulmonary toxicity compared to other bleomycin variants.

InChIKey

CWCMIVBLVUHDHK-ZSNHEYEWSA-N

安全信息

SureRoute逆合成路线

1.  11031-11-1 逆合成路线 1

—
—
ACMDZU859
11031-11-1
来源: SureRoute

2.  11031-11-1 逆合成路线 2

—
—
ACMDZU859
11031-11-1
来源: SureRoute

3.  11031-11-1 逆合成路线 3

—
—
ACMDZU859
11031-11-1
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手